Operator: Greetings, welcome to the Moleculin Biotech 2023 Year-End Conference Call and Webcast. [Operator Instructions] Please note, that this conference is being recorded.
– Annamycin in combination with Cytarabine achieves CRc rate of 60% in 2nd line AML subjects
– AnnAraC has potential to fill significant unmet need and expected to increase 2nd.
Moleculin Reports Full Year 2023 Financial Results menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.
StockNews.com assumed coverage on shares of Moleculin Biotech (NASDAQ:MBRX – Free Report) in a research note released on Wednesday. The firm issued a sell rating on the stock. Separately, HC Wainwright reiterated a buy rating and issued a $45.00 price target on shares of Moleculin Biotech in a research note on Thursday, December 14th. Get […]
Moleculin to Present at the 36th Annual ROTH Conference marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.